Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

New agreement seeks to speed up UK research

February 25, 2011 Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA

The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
News
Pfizer research Sandwich, Kent

MPs to question Pfizer management over R&D closure

February 25, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …
News

Glioblastoma vaccine enters phase II

February 24, 2011 Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
News
Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011 Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
News

Online international research register launched

February 23, 2011 Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register

The UK government has backed the creation of a free, international online register to improve the transparency of health research. …
News
Lung cancer cells

No magic bullet, but a growing arsenal against lung cancer

February 23, 2011 Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer

A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …
Feature

J&J hepatitis C drug begins phase III trials

February 23, 2011 Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
News

Contract research news in brief

February 23, 2011 Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia

Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …
News
ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011 Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …
Appointment

Sanofi partners on dengue vaccine awareness

February 22, 2011 Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
News

Scottish biotech ProStrakan sold for £292m

February 22, 2011 Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech

Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
News

Trial failures threaten UK biotech

February 18, 2011 Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech

A number of late stage failures from British biotech firms have left a looming question mark over the future of …
News

e-Therapeutics success in £17 million financing

February 17, 2011 Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics

UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …
News
Tyverb

Pharma industry R&D pipelines

February 16, 2011 Research and Development pipeline, pipelines

 New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …
Feature
Lilly HQ

Lilly hails progress of new R&D approaches

February 16, 2011 Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly

Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025